Australia markets closed

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
169.74+0.27 (+0.16%)
At close: 04:00PM EST
169.98 +0.24 (+0.14%)
After hours: 07:59PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 39.19B
Enterprise value 25.55B
Trailing P/E 3.91
Forward P/E 8.71
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.17
Price/book (mrq)2.06
Enterprise value/revenue 1.38
Enterprise value/EBITDA 1.75

Trading information

Stock price history

Beta (5Y monthly) 0.12
52-week change 3-39.44%
S&P500 52-week change 3-11.22%
52-week high 3321.86
52-week low 3117.08
50-day moving average 3144.64
200-day moving average 3151.82

Share statistics

Avg vol (3-month) 3892.16k
Avg vol (10-day) 3796.33k
Shares outstanding 5242.68M
Implied shares outstanding 6N/A
Float 890.02M
% held by insiders 162.96%
% held by institutions 116.95%
Shares short (14 Nov 2022) 41.88M
Short ratio (14 Nov 2022) 41.76
Short % of float (14 Nov 2022) 4N/A
Short % of shares outstanding (14 Nov 2022) 40.77%
Shares short (prior month 13 Oct 2022) 42.21M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 316 June 2022
Ex-dividend date 401 June 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 55.60%
Operating margin (ttm)68.09%

Management effectiveness

Return on assets (ttm)42.83%
Return on equity (ttm)76.24%

Income statement

Revenue (ttm)18.56B
Revenue per share (ttm)76.34
Quarterly revenue growth (yoy)-43.10%
Gross profit (ttm)16.07B
EBITDA 12.73B
Net income avi to common (ttm)10.32B
Diluted EPS (ttm)41.88
Quarterly earnings growth (yoy)-44.40%

Balance sheet

Total cash (mrq)13.43B
Total cash per share (mrq)55.9
Total debt (mrq)274M
Total debt/equity (mrq)1.49
Current ratio (mrq)5.37
Book value per share (mrq)76.45

Cash flow statement

Operating cash flow (ttm)12.55B
Levered free cash flow (ttm)10.2B